Figure 1

(A) Schematic representation of a zebrafish heart. The heart consists of a ventricle, atrium, and outflow tract. (B) BirA2-GFP is expressed in cardiomyocytes via the cmlc2 promoter. Section of ventricle from cmlc2:birA2-GFP transgenic animal. BirA2 is distributed throughout the cardiomyocytes, including the nucleus. DAPI staining and native GFP signal are shown. (C) BirA2-GFP-CAAX is expressed in cardiomyocytes via the cmlc2 promoter. Section of ventricle from cmlc2:bira2-GFP-CAAX transgenic animal. The CAAX-tag localizes BirA2 to the membranes of cardiomyocytes. (D) Timeline of biotin administration by intraperitoneal injections (IP injections). (E) Western blot analysis of biotinylation activity of BirA2-GFP-expressing ventricles. BirA2 is functional and biotinylates sufficiently after three daily biotin injections. Endogenous biotinylated carboxylase was detected in untreated and biotin-treated hearts. (F) Western blot analysis of BirA2-GFP-CAAX-expressing ventricles. BirA2 is functional and biotinylates sufficiently after three daily injections with biotin. WT: wild type. (G) Schematic summary of BioID2 assay on uninjured zebrafish hearts. (H) Over-representation test for cellular components. BioID2 for BirA-GFP-CAAX enriches for membrane-associated proteins. 343 total proteins were gated at a 2.5-fold change when normalized to BirA-GFP. p<0.001, false discovery rate (FDR) < 0.015%. dpt: days post treatment. Scale bar in images, 50 μm; magnification scale bar: 10 μm.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Elife